Scarica l'app Stockscreener
1.60
0.00%
0.00
Dopo l'orario di chiusura:
1.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Pluri Inc Borsa (PLUR) Ultime notizie
Pluri Subsidiary Acquires Fishway to Expand Cultivated Seafood - tipranks.com
Pluri's Ever After Foods Expands Cultivated-Protein Platform Through Fishway Acquisition and Strategic Investment - GlobeNewswire
Pluri Inc (PLUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Pluri Inc. Revenue Breakdown – NASDAQ:PLUR - TradingView
Pluri Inc (PLUR) Stock News Today - TradingKey
Pluri Inc (PLUR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Cellav Health and Aesthetics Ltd Completes Regulatory Registration of Regenativo+ in the UK - marketscreener.com
Pluri's subsidiary Cellav completes UK regulato... - Pluang
Pluri subsidiary completes UK regulatory registration for aesthetics product - Investing.com
Pluri’s Regenativo+ Is Registered for Sale in a $900M UK Market - Stock Titan
Pluri Inc (PLUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Pluri Inc. (PLUR) Gains Slightly as Stock Tests Key Resistance Near $1.76Wave Equality - dars.gov.et
Pluri Inc (PLUR) Balance Sheet - TradingKey
PLUR|Pluri Inc|Price:1.550|Chg%:-0.010 - TradingKey
Pluri Inc (PLUR) Cash Flow - TradingKey
Pluri Inc (PLUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PLUR|Pluri Inc|Price:1.640| - TradingKey
Pluri Inc (PLUR) Earnings Date & Reports & Earnings News - TradingKey
Pluri Inc (PLUR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Pluri Inc (PLUR) Institutional Confidence - TradingKey
PLUR|Pluri Inc|Price:1.780|Chg%:-0.040 - TradingKey
Pluri Inc. Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D InvestmentsProfit Guidance Range - dars.gov.et
Pluri Inc (PLUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Pluri Inc (PLUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Enterprise value to revenue forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Enterprise value to revenue forward of Pluri Inc. – FWB:4DX - TradingView
Plurilock Security Inc.'S Aurora Subsidiary Announces Selection as SEWP VI Awardee Enabling U.S. Federal Agencies to Procure It and Cybersecurity Solutions - marketscreener.com
Pluri Inc. (PLUR) Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEPS Revision Trend - dars.gov.et
Pluri Inc. (PLUR) Rallies 3.33% from Support: Key Levels to WatchReversal Setup Alerts - dars.gov.et
Price to book forward of Pluri Inc. – LS:A408KW - TradingView
Pluri in ongoing talks to extend EIB financing - The Globe and Mail
Pluri Inc. Files 8-K: Company Updates, NASDAQ Listing, and EIB Loan Discussions – July 2026 - Minichart
Pluri chairman raises stake above 30%; shares up - MSN
Pluri's Chairman Increases Investment and Ownership Stake (PLUR) - GuruFocus
Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30% - marketscreener.com
Pluri Chairman Builds 30%-Plus Position With $17M Investment - Stock Titan
Pluri Receives Nasdaq Non-Compliance Notice, Faces Delisting Risk - TipRanks
Pluri Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Pluri Inc. Q2 2026 Earnings: EPS Miss Reflects Ongoing R&D InvestmentOne-Time Gain Impact - dars.gov.et
Pluri Inc. (PLUR) Q2 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues R&D InvestmentNon-GAAP Earnings - dars.gov.et
Pluri (PLUR) director Doron Shorrer files Form 3 listing share holdings - Stock Titan
PLURPluri Inc Latest SEC Filings - Finviz
Pluri Inc. Q2 2026 Earnings: EPS Misses Estimates as Stock Holds SteadyDividend Increase Stocks - dars.gov.et
Pluri Inc. Q2 2026 Earnings: Wider-than-Expected Loss Drives Stock DeclineSlow Growth Warning - dars.gov.et
Pluri (NASDAQ: PLUR) director logs RSU grant as 625,000 warrants expire - Stock Titan
Synthetic Stem Cell Market to Witness Massive Growth by 2033 | - openPR.com
Form 13D/A Pluri Inc. For: 1 July By Investing.com - Investing.com UK
Price to sales forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Enterprise value to EBITDA forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Price to earnings forward of Pluri Inc. – NASDAQ:PLUR - TradingView
Price to earnings forward of Pluri Inc. – TASE:PLUR - TradingView
Pluri Inc. Actuals & Estimates (NASDAQ:PLUR) - TradingView
Pluri Inc. Actuals & Estimates (FWB:4DX) - TradingView
Pluri Inc. Actuals & Estimates (TASE:PLUR) - TradingView
Brevel and Coffeesai Trial Illuminated Fermentation to Push Cell-Based Coffee Toward Commercial Scale - Cultivated X
RGNT PE Ratio & Valuation, Is RGNT Overvalued - Intellectia AI
Pluri Secures Insider Advance Subscription to Boost Liquidity - TipRanks
Pluri (NASDAQ: PLUR) gets $1,250,000 insider advance and appoints new director - Stock Titan
Pluri Arranges $1.25 Million Advance Subscription With Chutzpah Holdings Ahead of Planned Offering - TradingView
PLUR Q1 2026 Earnings: EPS Miss Drives Double-Digit Stock DeclineManagement Tone Analysis - dars.gov.et
Pluri Inc (PLUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
1.80%
1.77%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):